Please login to the form below

Not currently logged in
Email:
Password:

Biktarvy

This page shows the latest Biktarvy news and features for those working in and with pharma, biotech and healthcare.

Gilead’s Biktarvy received EC approval for the treatment of HIV in paediatric populations

Gilead’s Biktarvy received EC approval for the treatment of HIV in paediatric populations

After changing to Biktarvy, 98% of patients in two groups were suppressed at week 48. ... After switching to Biktarvy, 98% of participants in both cohorts 1 and 2 remained suppressed at week 48.

Latest news

More from news
Approximately 7 fully matching, plus 18 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Mednet Group

PMEA Agency of the year 2021. With diversity and inclusion at our core, Mednet Group consists of Attigo CIC and...

Latest intelligence

Whitepaper: Closing the gap with compelling healthcare communications
Want to learn how to close the distance between a person’s current health and their healthiest possible self?...
Healing the Healers
Because if we do not heal the healers, who is going to heal us?...
The (inevitable) digital transformation of Medical Affairs
It’s not a question of ‘if,’ it’s a question of ‘when.’...